NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

It’s ultimately the failure of the management. The reality is they have been unable to build excitement amongst big investor community. That’s a big part of their job.

Why aren’t they making presentations at big biotech investor conferences? Shorts or market makers are not preventing them from making these pitches. At the very least, they ought to make sincere efforts towards that and not make excuses all the time.

It wouldn’t be surprising if we see a similar reaction to the share price at the UK approval PR like what we saw with JAMA, TLD, and MIA. Shorts will highlight issues around reimbursements, investments around manufacturing scale up, etc. Management has shown time and again that they are unable to control the narrative, build excitement, and bring big investors on board despite achieving these key milestones.

So it will be extremely difficult to build credibility, trust, and therefore meaningful support for the share price outside a big pharma partner.